Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

IL-6 and IL-1β expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria.

de Montjoye L, Choteau M, Herman A, Hendrickx E, Chéou P, Baeck M, Dumoutier L.

Allergy. 2019 May 24. doi: 10.1111/all.13928. [Epub ahead of print] No abstract available.

PMID:
31125442
2.

Increased expression of IL-24 in chronic spontaneous urticaria.

de Montjoye L, Herman A, Hendrickx E, Chéou P, Blanchetot C, Hofman E, Baeck M, Dumoutier L.

Allergy. 2019 Apr 21. doi: 10.1111/all.13832. [Epub ahead of print] No abstract available.

PMID:
31006117
3.

IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.

Van Belle AB, Cochez PM, de Heusch M, Pointner L, Opsomer R, Raynaud P, Achouri Y, Hendrickx E, Cheou P, Warnier G, Renauld JC, Baeck M, Dumoutier L.

Sci Rep. 2019 Feb 12;9(1):1852. doi: 10.1038/s41598-018-38156-4.

4.

Endogenous IL-22 is dispensable for experimental glomerulonephritis.

Gnirck AC, Wunderlich M, Becker M, Xiong T, Weinert E, Meyer-Schwesinger C, Dumoutier L, Renauld JC, Huber S, Panzer U, Turner JE.

Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F712-F722. doi: 10.1152/ajprenal.00303.2018. Epub 2019 Feb 6.

PMID:
30724106
5.

Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux VFJ, Sokol H, Ryffel B.

Mucosal Immunol. 2019 Jan;12(1):290. doi: 10.1038/s41385-018-0112-6.

PMID:
30504789
6.

Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.

de Montjoye L, Herman A, Dumoutier L, Lambert M, Tromme I, Baeck M.

Ann Allergy Asthma Immunol. 2018 Nov;121(5):620-622. doi: 10.1016/j.anai.2018.07.002. Epub 2018 Jul 6. No abstract available.

PMID:
30392532
7.

Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine.

Baeck M, Herman A, de Montjoye L, Hendrickx E, Chéou P, Cochez PM, Dumoutier L.

Contact Dermatitis. 2018 Dec;79(6):346-355. doi: 10.1111/cod.13123. Epub 2018 Sep 28.

PMID:
30264909
8.

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation.

Gaignage M, Marillier RG, Cochez PM, Dumoutier L, Uyttenhove C, Coutelier JP, Van Snick J.

Haematologica. 2019 Feb;104(2):392-402. doi: 10.3324/haematol.2018.195628. Epub 2018 Sep 13.

9.

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Chamaillard M, Quesniaux V, Sokol H, Chamaillard M, Ryffel B.

Mucosal Immunol. 2018 Jul;11(4):1181-1190. doi: 10.1038/s41385-018-0005-8. Epub 2018 May 4. Erratum in: Mucosal Immunol. 2019 Jan;12(1):290.

PMID:
29728643
10.

Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model.

Broquet A, Jacqueline C, Davieau M, Besbes A, Roquilly A, Martin J, Caillon J, Dumoutier L, Renauld JC, Heslan M, Josien R, Asehnoune K.

Sci Rep. 2017 Sep 8;7(1):11010. doi: 10.1038/s41598-017-11518-0.

11.

Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.

Martin JC, Wolk K, Bériou G, Abidi A, Witte-Händel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld JC, Sabat R, Josien R.

J Immunol. 2017 May 1;198(9):3671-3678. doi: 10.4049/jimmunol.1700021. Epub 2017 Mar 29.

12.

Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells.

Cochez PM, Michiels C, Hendrickx E, Dauguet N, Warnier G, Renauld JC, Dumoutier L.

J Invest Dermatol. 2017 May;137(5):1094-1103. doi: 10.1016/j.jid.2016.12.023. Epub 2017 Jan 20.

13.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C.

Infect Immun. 2017 Jan 26;85(2). pii: e00806-16. doi: 10.1128/IAI.00806-16. Print 2017 Feb.

14.

AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model.

Cochez PM, Michiels C, Hendrickx E, Van Belle AB, Lemaire MM, Dauguet N, Warnier G, de Heusch M, Togbe D, Ryffel B, Coulie PG, Renauld JC, Dumoutier L.

Eur J Immunol. 2016 Jun;46(6):1449-59. doi: 10.1002/eji.201546070.

15.

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection.

Hernández PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hoelscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A.

Nat Immunol. 2015 Jul;16(7):698-707. doi: 10.1038/ni.3180. Epub 2015 May 25.

16.

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.

Cuende J, Liénart S, Dedobbeleer O, van der Woning B, De Boeck G, Stockis J, Huygens C, Colau D, Somja J, Delvenne P, Hannon M, Baron F, Dumoutier L, Renauld JC, De Haard H, Saunders M, Coulie PG, Lucas S.

Sci Transl Med. 2015 Apr 22;7(284):284ra56. doi: 10.1126/scitranslmed.aaa1983.

17.

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.

Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T, Denis RG, Cochez P, Pierard F, Castel J, Bindels LB, Plovier H, Robine S, Muccioli GG, Renauld JC, Dumoutier L, Delzenne NM, Luquet S, Bäckhed F, Cani PD.

Nat Commun. 2014 Dec 5;5:5648. doi: 10.1038/ncomms6648.

18.

Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study.

Buysschaert M, Baeck M, Preumont V, Marot L, Hendrickx E, Van Belle A, Dumoutier L.

Br J Dermatol. 2014 Jul;171(1):155-61. doi: 10.1111/bjd.12886. Epub 2014 Jul 16.

PMID:
24506139
19.

Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids.

Baeck M, Soria A, Marot L, Theate I, Hendrickx E, Van Belle A, Goossens A, Tennstedt D, Dachelet C, Jaeger J, Pilette C, Renauld JC, Van Baren N, Rozières A, Nicolas JF, Dumoutier L.

Contact Dermatitis. 2013 Jun;68(6):357-68. doi: 10.1111/cod.12040.

PMID:
23692036
20.

Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, Blanc F, De Trez C, Van Maele L, Dumoutier L, Huerre MR, Eberl G, Si-Tahar M, Gosset P, Renauld JC, Sirard JC, Faveeuw C, Trottein F.

J Virol. 2013 Jun;87(12):6911-24. doi: 10.1128/JVI.02943-12. Epub 2013 Apr 17.

21.

Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, Carlier Y, Letesson JJ, Muraille E.

Infect Immun. 2012 Dec;80(12):4271-80. doi: 10.1128/IAI.00761-12. Epub 2012 Sep 24.

22.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, Dumoutier L, Ryffel B, Renauld JC, Gosset P, Gosset P, Si-Tahar M, Faveeuw C, Trottein F.

J Biol Chem. 2012 Mar 16;287(12):8816-29. doi: 10.1074/jbc.M111.304758. Epub 2012 Jan 31.

23.

IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.

Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L.

J Immunol. 2012 Jan 1;188(1):462-9. doi: 10.4049/jimmunol.1102224. Epub 2011 Nov 30.

24.

Dual TCR expression biases lung inflammation in DO11.10 transgenic mice and promotes neutrophilia via microbiota-induced Th17 differentiation.

Lemaire MM, Dumoutier L, Warnier G, Uyttenhove C, Van Snick J, de Heusch M, Stevens M, Renauld JC.

J Immunol. 2011 Oct 1;187(7):3530-7. doi: 10.4049/jimmunol.1101720. Epub 2011 Aug 22.

25.

IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality.

Dumoutier L, de Heusch M, Orabona C, Satoh-Takayama N, Eberl G, Sirard JC, Di Santo JP, Renauld JC.

Eur J Immunol. 2011 Apr;41(4):1075-85. doi: 10.1002/eji.201040878. Epub 2011 Mar 14.

26.

Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane protein.

Lemaire MM, Vanhaudenarde A, Nizet Y, Dumoutier L, Renauld JC.

J Immunol Methods. 2011 Mar 31;367(1-2):56-62. doi: 10.1016/j.jim.2011.02.001. Epub 2011 Feb 17.

PMID:
21334341
27.

Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A.

Besnard AG, Sabat R, Dumoutier L, Renauld JC, Willart M, Lambrecht B, Teixeira MM, Charron S, Fick L, Erard F, Warszawska K, Wolk K, Quesniaux V, Ryffel B, Togbe D.

Am J Respir Crit Care Med. 2011 May 1;183(9):1153-63. doi: 10.1164/rccm.201008-1383OC. Epub 2011 Feb 4.

PMID:
21297073
28.

TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.

Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I, Janot L, Erard F, Bertout J, Leger H, Sebbane F, Benecke A, Renauld JC, Hardt WD, Ryffel B, Sirard JC.

J Immunol. 2010 Jul 15;185(2):1177-85. doi: 10.4049/jimmunol.1000115. Epub 2010 Jun 21.

29.

Structure and function of interleukin-22 and other members of the interleukin-10 family.

Trivella DB, Ferreira-Júnior JR, Dumoutier L, Renauld JC, Polikarpov I.

Cell Mol Life Sci. 2010 Sep;67(17):2909-35. doi: 10.1007/s00018-010-0380-0. Epub 2010 May 8. Review.

PMID:
20454917
30.

IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis.

Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, Uwambayinema F, Marien B, van den Brûle S, Van Snick J, Uyttenhove C, Ryffel B, Renauld JC, Lison D, Huaux F.

J Immunol. 2010 Jun 1;184(11):6367-77. doi: 10.4049/jimmunol.0900459. Epub 2010 Apr 26.

31.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

32.

New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain.

Dumoutier L, de Meester C, Tavernier J, Renauld JC.

J Biol Chem. 2009 Sep 25;284(39):26377-84. doi: 10.1074/jbc.M109.007955. Epub 2009 Jul 24.

33.

Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22.

de Moura PR, Watanabe L, Bleicher L, Colau D, Dumoutier L, Lemaire MM, Renauld JC, Polikarpov I.

FEBS Lett. 2009 Apr 2;583(7):1072-7. doi: 10.1016/j.febslet.2009.03.006. Epub 2009 Mar 11.

34.

Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to its soluble decoy receptor IL-22BP.

Watanabe L, de Moura PR, Nascimento AS, Colau D, Dumoutier L, Renauld JC, Polikarpov I.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Feb 1;65(Pt 2):102-4. doi: 10.1107/S1744309108042309. Epub 2009 Jan 7.

35.

Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice.

Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, Matthys P.

Arthritis Rheum. 2009 Feb;60(2):390-5. doi: 10.1002/art.24220.

36.

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.

Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P.

PLoS Pathog. 2008 Sep 12;4(9):e1000151. doi: 10.1371/journal.ppat.1000151.

37.

Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism.

Bleicher L, de Moura PR, Watanabe L, Colau D, Dumoutier L, Renauld JC, Polikarpov I.

FEBS Lett. 2008 Sep 3;582(20):2985-92. doi: 10.1016/j.febslet.2008.07.046. Epub 2008 Aug 7.

38.

Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.

Kapessidou P, Poulin L, Dumoutier L, Goldman M, Renauld JC, Braun MY.

Transplant Proc. 2008 Jun;40(5):1593-7. doi: 10.1016/j.transproceed.2008.03.151.

PMID:
18589157
39.

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.

Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B.

Nature. 2008 May 1;453(7191):106-9. doi: 10.1038/nature06881. Epub 2008 Mar 23.

PMID:
18362914
40.

Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.

Kreis S, Philippidou D, Margue C, Rolvering C, Haan C, Dumoutier L, Renauld JC, Behrmann I.

PLoS One. 2007 Dec 12;2(12):e1300.

41.

IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis.

Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B.

J Immunol. 2007 Dec 15;179(12):8098-104.

42.

Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.

de Oliveira Neto M, Ferreira JR Jr, Colau D, Fischer H, Nascimento AS, Craievich AF, Dumoutier L, Renauld JC, Polikarpov I.

Biophys J. 2008 Mar 1;94(5):1754-65. Epub 2007 Nov 16.

43.

Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus.

Le-Thi-Phuong T, Dumoutier L, Renauld JC, Van Snick J, Coutelier JP.

Int Immunol. 2007 Nov;19(11):1303-11. Epub 2007 Oct 3.

PMID:
17914119
44.

Interleukin-22 and its crystal structure.

Nagem RA, Ferreira Júnior JR, Dumoutier L, Renauld JC, Polikarpov I.

Vitam Horm. 2006;74:77-103. Review.

PMID:
17027512
45.

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L, Huang J, Renauld JC, Kotenko SV, Roederer M, Beeler JA, Donnelly RP, Collins PL, Rabin RL.

J Virol. 2006 May;80(10):5032-40.

46.

The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains.

Hör S, Pirzer H, Dumoutier L, Bauer F, Wittmann S, Sticht H, Renauld JC, de Waal Malefyt R, Fickenscher H.

J Biol Chem. 2004 Aug 6;279(32):33343-51. Epub 2004 Jun 3.

47.

A new member of the interleukin 10-related cytokine family encoded by a poxvirus.

Bartlett NW, Dumoutier L, Renauld JC, Kotenko SV, McVey CE, Lee HJ, Smith GL.

J Gen Virol. 2004 Jun;85(Pt 6):1401-12.

PMID:
15166422
48.

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.

Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC.

J Biol Chem. 2004 Jul 30;279(31):32269-74. Epub 2004 May 27.

49.

Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.

Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, Anantha S, Dickensheets H, Dumoutier L, Renauld JC, Zdanov A, Donnelly RP, Kotenko SV.

J Immunol. 2004 Feb 15;172(4):2006-10.

50.

Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.

Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S.

Cancer Res. 2003 Aug 15;63(16):5105-13. Erratum in: Cancer Res. 2004 Feb 15;64(4):1559. Boquio Amelia [corrected to Boquoi Amelie].

Supplemental Content

Loading ...
Support Center